Modulation of human neutrophil superoxide production by selective thromboxane synthetase inhibitor U63, 557A

This publication has 21 references indexed in Scilit:

• Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease
  The American Journal of Medicine, 1988
• Reduction in myocardial neutrophil accumulation and infarct size following administration of thromboxane inhibitor U-63,557A
  American Heart Journal, 1987
• Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
  Circulation Research, 1987
• Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation
  American Heart Journal, 1987
• Free radicals and myocardial injury: pharmacologic implications.
  Circulation, 1986
• Leukocytes and Ischemia-Induced Myocardial Injury
  Annual Review of Pharmacology and Toxicology, 1986
• Anti-ischemic actions of a new throm☐ane receptor antagonist during acute myocardial ischemia in cats
  American Heart Journal, 1985
• Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction
  Prostaglandins, Leukotrienes and Medicine, 1985
• Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate
  Prostaglandins, 1983
• Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils
  Biochemical and Biophysical Research Communications, 1983